BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 24924144)

  • 1. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
    Linnartz-Gerlach B; Mathews M; Neumann H
    Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siglec functions of microglia.
    Linnartz-Gerlach B; Kopatz J; Neumann H
    Glycobiology; 2014 Sep; 24(9):794-9. PubMed ID: 24833613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx.
    Linnartz B; Neumann H
    Glia; 2013 Jan; 61(1):37-46. PubMed ID: 22615186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst.
    Claude J; Linnartz-Gerlach B; Kudin AP; Kunz WS; Neumann H
    J Neurosci; 2013 Nov; 33(46):18270-6. PubMed ID: 24227736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleviation of neurotoxicity by microglial human Siglec-11.
    Wang Y; Neumann H
    J Neurosci; 2010 Mar; 30(9):3482-8. PubMed ID: 20203208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
    Roy S; Mandal C
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
    Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
    Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siglecs in Brain Function and Neurological Disorders.
    Siddiqui SS; Matar R; Merheb M; Hodeify R; Vazhappilly CG; Marton J; Shamsuddin SA; Al Zouabi H
    Cells; 2019 Sep; 8(10):. PubMed ID: 31546700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tools to study and target the Siglec-sialic acid axis in cancer.
    Läubli H; Kawanishi K; George Vazhappilly C; Matar R; Merheb M; Sarwar Siddiqui S
    FEBS J; 2021 Nov; 288(21):6206-6225. PubMed ID: 33251699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation.
    Linnartz B; Wang Y; Neumann H
    Int J Alzheimers Dis; 2010 Jun; 2010():. PubMed ID: 20721346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease.
    Gonzalez-Gil A; Porell RN; Fernandes SM; Maenpaa E; Li TA; Li T; Wong PC; Aoki K; Tiemeyer M; Yu ZJ; Orsburn BC; Bumpus NN; Matthews RT; Schnaar RL
    J Biol Chem; 2022 Jun; 298(6):101960. PubMed ID: 35452678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells.
    Lock K; Zhang J; Lu J; Lee SH; Crocker PR
    Immunobiology; 2004; 209(1-2):199-207. PubMed ID: 15481154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoproteomics identifies microglial Siglec-F inflammatory response during neurodegeneration.
    Morshed N; Ralvenius WT; Nott A; Watson LA; Rodriguez FH; Akay LA; Joughin BA; Pao PC; Penney J; LaRocque L; Mastroeni D; Tsai LH; White FM
    Mol Syst Biol; 2020 Dec; 16(12):e9819. PubMed ID: 33289969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells.
    Tsubata T
    Int Immunol; 2023 Oct; 35(10):461-473. PubMed ID: 37504378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.
    Dong J; Wei Y; Ye X; Sun C; Tian Y; Lu M; Du J; Chen Z
    Mol Immunol; 2016 May; 73():158-69. PubMed ID: 26847490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery, classification, evolution and diversity of Siglecs.
    Angata T; Varki A
    Mol Aspects Med; 2023 Apr; 90():101117. PubMed ID: 35989204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins.
    Brinkman-Van der Linden EC; Varki A
    J Biol Chem; 2000 Mar; 275(12):8625-32. PubMed ID: 10722702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siglecs at the Host-Pathogen Interface.
    Chang YC; Nizet V
    Adv Exp Med Biol; 2020; 1204():197-214. PubMed ID: 32152948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.